Phoenix Venture Partners Ltd.

Phoenix Venture Partners is a US-based venture firm with a deep specialization in advanced materials, deep-tech and adjacent industrial technology, with selective exposure to life sciences, medical devices and healthcare-adjacent platforms where novel materials or advanced manufacturing create competitive moats. The firm typically invests at seed and Series A in technical companies with strong IP foundations, often emerging from university or corporate R&D environments, and partners with corporate strategics for commercialization support. Check sizes typically sit in the $1M to $5M range at initial investment, with capacity to lead small Series A rounds and meaningful follow-on reserves. For healthcare founders, Phoenix is most relevant if you are building a medical device, diagnostic, drug delivery, biomaterials or healthcare-adjacent platform where advanced materials science or specialty manufacturing is a core technical edge. The firm is a poor fit for digital-only health, healthcare services, AI-only software, and most consumer health businesses where the technical moat is software rather than physical or chemical. Founders should expect rigorous technical diligence, hands-on partner involvement on IP and manufacturing strategy, and longer hold periods consistent with deep-tech investing. Entry is best via warm introductions from technical advisors, university tech-transfer offices, deep-tech-focused co-investors or corporate partners in the Phoenix network. LinkedIn outreach is workable but should lead with a sharp articulation of the technical moat and commercial pathway. Confirm fund stage, current deployment pace and healthcare-specific position count in any first conversation.